Advanced

Human immunoglobulin G levels of viruses and associated glioma risk

Sjostrom, Sara; Hjalmars, Ulf; Juto, Per; Wadell, Goran; Hallmans, Goran; Tjonneland, Anne; Halkjaer, Jytte; Manjer, Jonas LU ; Almquist, Martin LU and Melin, Beatrice S. (2011) In Cancer Causes and Control 22(9). p.1259-1266
Abstract
Few consistent etiological factors have been identified for primary brain tumors. Inverse associations to asthma and low levels of varicella-zoster virus, immunoglobulin (Ig) levels in prevalent cases have indicted a role for the immune system in the development of glioma. Because samples from prevalent cases of glioma could be influenced by treatments such as steroids and chemotherapy, we investigated pre-diagnostic samples from three large Scandinavian cohorts. To test the hypothesis that immune response levels to these viruses are associated etiologically with glioma risk, we investigated pre-diagnostic immunoglobulin levels for cytomegalovirus (CMV), varicella-zoster virus (VZV), adenovirus (Ad), and Epstein-Barr virus (EBV) including... (More)
Few consistent etiological factors have been identified for primary brain tumors. Inverse associations to asthma and low levels of varicella-zoster virus, immunoglobulin (Ig) levels in prevalent cases have indicted a role for the immune system in the development of glioma. Because samples from prevalent cases of glioma could be influenced by treatments such as steroids and chemotherapy, we investigated pre-diagnostic samples from three large Scandinavian cohorts. To test the hypothesis that immune response levels to these viruses are associated etiologically with glioma risk, we investigated pre-diagnostic immunoglobulin levels for cytomegalovirus (CMV), varicella-zoster virus (VZV), adenovirus (Ad), and Epstein-Barr virus (EBV) including the nuclear antigen (EBNA1) using plasma samples from 197 cases of adult glioma and 394 controls collected from population-based cohorts in Sweden and Denmark. Low VZV IgG levels were marginally significantly more common in glioma cases than the controls (odds ratio (OR) = 0.68, 95% CI 0.41-1.13) for the fourth compared with the first quartile (p = 0.06 for trend). These results were more prominent when analyzing cases with blood sampling at least 2 years before diagnosis (OR = 0.63, 95% CI 0.37-1.08) (p = 0.03). No association with glioma risk was observed for CMV, EBV, and adenovirus. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Glioma, Glioblastoma, Immunoglobulin G, Virus, Case-control study
in
Cancer Causes and Control
volume
22
issue
9
pages
1259 - 1266
publisher
Springer
external identifiers
  • wos:000293296200004
ISSN
1573-7225
DOI
10.1007/s10552-011-9799-3
language
English
LU publication?
yes
id
ab5be44c-e4cc-48af-aa94-7768a8943bac (old id 2072397)
date added to LUP
2011-09-02 08:31:44
date last changed
2016-04-15 15:53:39
@article{ab5be44c-e4cc-48af-aa94-7768a8943bac,
  abstract     = {Few consistent etiological factors have been identified for primary brain tumors. Inverse associations to asthma and low levels of varicella-zoster virus, immunoglobulin (Ig) levels in prevalent cases have indicted a role for the immune system in the development of glioma. Because samples from prevalent cases of glioma could be influenced by treatments such as steroids and chemotherapy, we investigated pre-diagnostic samples from three large Scandinavian cohorts. To test the hypothesis that immune response levels to these viruses are associated etiologically with glioma risk, we investigated pre-diagnostic immunoglobulin levels for cytomegalovirus (CMV), varicella-zoster virus (VZV), adenovirus (Ad), and Epstein-Barr virus (EBV) including the nuclear antigen (EBNA1) using plasma samples from 197 cases of adult glioma and 394 controls collected from population-based cohorts in Sweden and Denmark. Low VZV IgG levels were marginally significantly more common in glioma cases than the controls (odds ratio (OR) = 0.68, 95% CI 0.41-1.13) for the fourth compared with the first quartile (p = 0.06 for trend). These results were more prominent when analyzing cases with blood sampling at least 2 years before diagnosis (OR = 0.63, 95% CI 0.37-1.08) (p = 0.03). No association with glioma risk was observed for CMV, EBV, and adenovirus.},
  author       = {Sjostrom, Sara and Hjalmars, Ulf and Juto, Per and Wadell, Goran and Hallmans, Goran and Tjonneland, Anne and Halkjaer, Jytte and Manjer, Jonas and Almquist, Martin and Melin, Beatrice S.},
  issn         = {1573-7225},
  keyword      = {Glioma,Glioblastoma,Immunoglobulin G,Virus,Case-control study},
  language     = {eng},
  number       = {9},
  pages        = {1259--1266},
  publisher    = {Springer},
  series       = {Cancer Causes and Control},
  title        = {Human immunoglobulin G levels of viruses and associated glioma risk},
  url          = {http://dx.doi.org/10.1007/s10552-011-9799-3},
  volume       = {22},
  year         = {2011},
}